$OPXA News Opexa, BreitBurn, Hudson Pacific price

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$OPXA News

Opexa, BreitBurn, Hudson Pacific price offerings 1:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 10:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 1:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 11:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy

Opexa Is Personalizing The Treatment Of Autoimmune Disease 9:24 a.m. June 3, 2014 - Seeking Alpha
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs 3:29 a.m. May 16, 2014 - Seeking Alpha
10-Q: OPEXA THERAPEUTICS, INC. 4:09 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T 9:00 a.m. April 30, 2014 - Seeking Alpha
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Opexa Therapeutics: A Long-Term Perspective For Price Appreciation 12:04 p.m. March 10, 2014 - Seeking Alpha
Will Opexa Become A Multi Bagger? 1:19 p.m. Feb. 21, 2014 - Seeking Alpha
Weekly CFO Buys Highlight 12:32 p.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 12:44 p.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 2:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 3:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 9:56 a.m. Aug. 8, 2013 - 247WallSt.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 3:36 p.m. Aug. 7, 2013 - 247WallSt.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 3:25 a.m. April 8, 2013 - InvestorPlace.com
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 9:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 3:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 9:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 10:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 4:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 3:22 p.m. Feb. 14, 2013 - Seeking Alpha


Top Gainers Technical Data -- Research on SolarCity, Clean Energy Fuel, Opexa Therapeutics, and Atossa Genetics 7:50 a.m. May 30, 2014 - PR Newswire - PRF
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 8:38 a.m. May 29, 2014 - GlobeNewswire
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis 8:02 a.m. May 13, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - BusinessWire - BZX
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020 12:33 p.m. April 23, 2014 - PR Newswire - PRF
Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting 8:01 a.m. April 22, 2014 - BusinessWire - BZX
RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies 10:24 a.m. April 21, 2014 - GlobeNewswire
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 10:19 a.m. April 10, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update 5:20 p.m. Feb. 27, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results 9:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
DELiA*s Path to Recovery Hampered By Sluggish Retail Marketplace 11:04 a.m. Feb. 24, 2014 - ACCESSWIRE
Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference 3:17 p.m. Feb. 11, 2014 - BusinessWire - BZX
Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference 10:00 a.m. Jan. 29, 2014 - BusinessWire - BZX
Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum 10:01 a.m. Jan. 23, 2014 - BusinessWire - BZX
Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 11:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 10:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 5:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 9:00 a.m. Dec. 16, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capricor Faces Lawsuit: Investors Should Take Note

Updated Category News Views 4

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 0

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Travel Smart: Support Wildlife, Avoid Exploitation

Updated Category News Views 1

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading
United Imaging's CE Mark Ignites CT Innovation in Europe

Updated Category News Views 5

United Imaging's Big Leap in CT Technology Listen up, folks. United Imaging just got the go-ahead to shake things up in Europe with their dual wide-coverage CT family. We're talking about the uCT SiriuX and the even more amped-up uCT SiriuX Ultrix. They’ve snagged the CE mark, a passport to roll out these impressive machines across the continent. Revolutionizing...

Continue Reading
Cypress Wood's Resilience in Louisiana's Humidity

Updated Category News Views 1

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Continue Reading
Drones Propel Precision Agriculture Market's Skyrocketing Growth

Updated Category News Views 2

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Continue Reading
Innventure Faces Securities Lawsuit After 74% Stock Drop

Updated Category News Views 2

Innventure's Stunning Plummet: A Lesson in Investor Caution Investors in Innventure, Inc. (NASDAQ: INV) got a harsh reminder of the market's volatility when the company's stock value nosedived by a staggering 74%. From May 27, 2026, just before the forensic bombshell by Morpheus Research, to August 14, 2026, Innventure's stock went from shaky to downright catastrophic....

Continue Reading
Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 2

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

Updated Category News Views 2

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...

Continue Reading

Top 5 Most Recently Viewed Articles

Huron Appoints Hope Katz as New General Counsel

Updated Category News Views 129

Huron Welcomes Hope Katz as General Counsel In an exciting development within the legal realm, globe-spanning professional services firm Huron (NASDAQ: HURN) has recently made a significant addition to its executive team. The firm has elevated Hope Katz to the position of executive vice president, general counsel, and corporate secretary, with her new role set to commence...

Continue Reading
Aston Martin's Growth Focus: Key Strategies and Insights Unveiled

Updated Category News Views 164

Aston Martin's Growth Focus: Key Strategies and Insights Unveiled Aston Martin's CEO Adrian Hallmark and CFO Doug Lafferty recently provided valuable insights into the company’s financial performance and future ambitions during an earnings call. Hallmark, who has settled into his role, emphasized the importance of the newly launched Vanquish and shared his excitement...

Continue Reading
Investigation into Possible Violations at Zuora and Others

Updated Category News Views 161

Halper Sadeh LLC's Investigation into Companies Halper Sadeh LLC, an esteemed law firm focused on investor rights, is currently exploring potential violations of federal securities laws involving several companies, including notable names like Zuora, Profire Energy, Future Vision II Acquisition Corp., and Hudson Acquisition I Corp. Details of the Investigations The...

Continue Reading
Navigating Dow Inc. Securities Lawsuit: Key Information for Investors

Updated Category News Views 183

Understanding the Dow Inc. Securities Lawsuit Investors have been notified of an important class action lawsuit involving Dow Inc. (NYSE: DOW). This legal action has been initiated by Levi & Korsinsky, LLP, aimed at protecting the rights of shareholders. This article will break down the essential aspects of the lawsuit and the implications for Dow investors. Who is...

Continue Reading
FDA Clears Momentis Anovo®: Revolution in Surgery

Updated Category News Views 7

The Evolution of Robotic Surgery There's a tide coming in the world of surgery, and Momentis Surgical is right at the crest. This isn't just another corporate cheer; we're talking about the FDA giving a green light to Momentis Surgical's Anovo® System. With this nod, the platform isn't bound by the chains of traditional robotic surgery systems. We're now looking at the...

Continue Reading